EUVIMEDEUVIMED entdecken
Open Access

High-molecular-weight Hyaluronan Administration Inhibits Bone Resorption and Promotes Bone Formation in Young-age Osteoporosis Rats

Toshiyuki Kikuchi, Kazuhiko Udagawa, Yoshihiro Sasazaki

Journal of Histochemistry & Cytochemistry · 2024

DOI: 10.1369/00221554241255724 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Histochemistry & Cytochemistry, 2024. Verfasst von Toshiyuki Kikuchi und 2 weiteren Autor:innen. Beteiligte Einrichtung: National Hospital Organization Murayama Medical Center, Tokyo, Japan. Hauptthemen laut MEDLINE: Bone Resorption, Hyaluronic Acid, Osteogenesis, Osteoporosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoporosis poses a significant global health concern, affecting both the elderly and young individuals, including athletes. Despite the development of numerous antiosteoporotic drugs, addressing the unique needs of young osteoporosis patients remains challenging. This study focuses on young rats subjected to ovariectomy (OVX) to explore the impact of high-molecular-weight hyaluronan (HA) on preventing OVX-induced osteoporosis. Twenty-four rats underwent OVX, while 12 underwent sham procedures (sham control group). Among the OVX rats, half received subcutaneous injections of HA (MW: 2700 kDa) at 10 mg/kg/week into their backs (OVX-HA group), whereas the other half received saline injections (0.5 ml/week) at the same site (OVX-saline group). OVX-HA group exhibited significantly higher percentages of osteoclast surface (Oc. S/BS), osteoblast surface per bone surface (Ob. S/BS), and bone volume/tissue volume (BV/TV) compared with OVX-saline group at the same age. The proportions of Ob. S/BS and BV/TV in the OVX-HA group closely resembled those of the sham control group, whereas the proportion of Oc. S/BS in the OVX-HA group was notably higher than that in the sham control group. In summary, the administration of HA significantly mitigated bone resorption and enhanced bone formation, suggesting a crucial role for HA in the treatment of young adult osteoporosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone ResorptionHyaluronic AcidOsteogenesisOsteoporosisFemaleRatsBone and BonesBone Density Conservation AgentsDisease Models, AnimalOsteoblastsOsteoclastsOvariectomyRats, Sprague-DawleyAnimals

Stichwörter der Autor:innen

bone metabolismbone morphometric analysishyaluronanjuvenile osteoporosis

Substanzen

Bone Density Conservation AgentsHyaluronic Acid

Autor:innen und Institutionen

  • National Hospital Organization Murayama Medical Center, Tokyo, Japan.
  • Department of Orthopedic Surgery, Keio University School of Medicine, Tokyo, Japan.

Zitieren

APA

Kikuchi, T., Udagawa, K., & Sasazaki, Y. (2024). High-molecular-weight Hyaluronan Administration Inhibits Bone Resorption and Promotes Bone Formation in Young-age Osteoporosis Rats. Journal of Histochemistry & Cytochemistry. https://doi.org/10.1369/00221554241255724

Vancouver

Kikuchi T, Udagawa K, Sasazaki Y. High-molecular-weight Hyaluronan Administration Inhibits Bone Resorption and Promotes Bone Formation in Young-age Osteoporosis Rats. Journal of Histochemistry & Cytochemistry. 2024. doi:10.1369/00221554241255724

BibTeX
@article{Kikuchi2024,
  author = {Kikuchi, Toshiyuki and Udagawa, Kazuhiko and Sasazaki, Yoshihiro},
  title = {High-molecular-weight Hyaluronan Administration Inhibits Bone Resorption and Promotes Bone Formation in Young-age Osteoporosis Rats},
  journal = {Journal of Histochemistry & Cytochemistry},
  year = {2024},
  doi = {10.1369/00221554241255724}
}
Kostenlos starten →